 Westport, CT, March 30, 2021 GLOBE NEWSWIRE -- BioSig Technologies, Inc. NASDAQ: BSGM BioSig or the Company, a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that the U.S. Patent Office had allowed a utility patent covering its PURE EPTM noise-filtering technology. The recently allowed patent application number 17082,564 entitled SYSTEMS AND METHODS FOR PERFORMING ELECTROPHYSIOLOGY EP SIGNAL PROCESSING was filed on October 28, 2020. The patent describes and claims systems and methods for filtering noise e.g., a cardiac signal during a quiet period. In particular, this patent involves filtering out harmonics and noise from an input cardiac signal. 